The best stocks to buy since 1993

Latest issue now available

Ergomed - Permira bids 1350p

September 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ERGO
  • Price:
  • 1350p
Ergomed shot ahead by £3 after announcing an agreed bid by private equity firm Permira for 1350p a share or around £703.1m. The price being paid for the contract research organisation represents a premium of approximately 28% to the day before the bid was unveiled and is a gain of 358% on the price originally recommended in the October ‘19 issue of SCSW at 295p. Permira is also offering an alternative to the cash offer. This would see eligible shareholders receive 451p in cash plus unlisted securities. Accept the cash offer. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X




To access our archive of articles and to receive current issues you need to subscribe